CDC Points Pointers on COVID-19 Vaccination After Allergic Reactions By Reuters

© Reuters. A health care worker takes the coronavirus disease (COVID-19) vaccine from a vial at the Martin Luther King Jr. Community Hospital in south Los Angeles

(Reuters) – The U.S. Centers for Disease Control and Prevention (CDC) announced Saturday that it is monitoring reports of allergic reactions to the COVID-19 vaccine and making recommendations on what to do with people with a history of allergies should proceed.

Anyone who has had a severe reaction to a COVID-19 vaccine shouldn’t get the second dose, the agency said, severely defining it as a need for the drug, epinephrine, or hospital treatment.

People who have had a severe allergic reaction to any component of a COVID-19 vaccine should avoid the vaccine formulation that contains the component, CDC said. In the US, two vaccines have been approved under emergency approvals.

Individuals with a history of severe allergic reactions to vaccines should consult their doctor regarding the COVID-19 shot. The CDC said people with severe allergies to food, pets, latex, or environmental conditions, as well as people with allergies to oral medications or a family history of severe allergic reactions, could still be vaccinated.

The US Food and Drug Administration is studying about five allergic reactions that have occurred to people after administration Pfizer Inc (NYSE 🙂 and BioNTech SE (NASDAQ 🙂 COVID-19 vaccine in the US this week.

On Friday the FDA said the Modern (NASDAQ 🙂 Inc vaccine approved for emergency use should not be given to anyone who has a history of severe allergic reaction to any component of the shot.

The UK regulator has stated that people with a history of anaphylaxis or severe allergic reactions to any drug or food should not receive the Pfizer-BioNTech COVID-19 vaccine.

Disclaimer: Fusion Media would like to remind you that the information contained on this website is not necessarily real-time or accurate. All CFDs (stocks, indices, futures) and forex prices are not provided by exchanges, but by market makers. Therefore, prices may not be accurate and may differ from the actual market price. This means that the prices are indicative and not suitable for trading purposes. Therefore, Fusion Media is not responsible for any trading losses you may suffer from using this data.

Fusion Media or anyone involved with Fusion Media assumes no liability for any loss or damage caused by reliance on the information contained on this website, such as data, offers, charts and buy / sell signals. Please be fully informed about the risks and costs associated with trading in the financial markets. This is one of the riskiest forms of investment possible.

Comments are closed.